Welcome to BaselBC - Basel Breast Consortium

Next event:

Mission:
The Basel Breast Consortium is an interdisciplinary organization committed to the development of basic, clinical and translational research projects by supporting interdisciplinary communication and mutual education in Switzerland and neighbouring cities. The presence of outstanding basic science groups, a university hospital and a medical faculty with strong clinical oncology departments, and numerous pharma companies make Basel well-positioned to be the nexus of these collaborative activities.

Vision:
To discuss, design and conduct scientific projects with the potential to advance knowledge in breast cancer basic biology and therapy to the highest level of targeted therapeutic efficacy while minimizing treatment-related toxicity.

Methodology:
The consortium’s mission is accomplished by regular meetings and networking opportunities among basic researchers, translational research scientists, clinicians - from academia and industry - dedicated to the study of mammary gland development, as well as breast cancer research and treatment in Switzerland and neighbouring cities. Participating clinicians and researchers may have a designated interest in basic or clinical research and originate from the fields of plastic, oncologic and oncoplastic surgery, radiation and medical oncology, gynecology, pathology, radiology and genetics. Participating basic researchers may originate, among others, from a variety of disciplines, including basic cell biology, genetics, immunology, computational biology, endocrinology and fundamental molecular biology.

We organize four joint lunchtime tandem meetings per year. The format is three 15 minutes presentations from basic/translational researchers, clinicians, and industry, while providing 15 additional minutes for discussion and networking.
We are confident that these interactions promote fruitful collaborations in the fields of breast development and breast cancer in Switzerland and neighbouring cities.

Coordinators

  • Mohamed Bentires-Alj (Momo), Pharm, Ph.D. Department of Biomedicine, University Hospital Basel
    Webpage
  • Walter P. Weber, Prof. Dr. Chief, Breast Surgery Unit, University Hospital of Basel
    Webpage
  • Christoph Rochlitz, Prof. Dr. Head of the Tumour Center of the University Hospital Basel
    Webpage - Oncology department - CCRC website
  • Gerhard Christofori, Prof. Dr. Department of Biomedicine, University of Basel
    Webpage
  • Nicola Aceto, Prof. Dr. Department of Biomedicine, University of Basel
    Webpage
  • Simone Muenst Soysal, Dr. Department of Pathology, University of Basel
    Webpage
  • Ana Correia, Dr.Department of Biomedecine, University of Basel
    Webpage
  • Barbara Szczerba Department of Biomedecine, University of Basel
    Webpage

 

BBC honorary members

  • Prof. Max Burger
  • Prof. Dr. med. Hans-Jörg Senn
  • Prof. Felix Harder
  • Prof. Richard Herrmann
  • Prof. Nancy Hynes
  • Prof. Peter Meier-Abt

Upcoming Events

News

Please communicate your new publications and awards in the fields of breast development and cancer to M. Bentires-Alj.


Sep 27 2016: Congratulations to BBC member Dr. Elisabeth A Kappos who was recently awarded the Scholarship of the Swiss Society of Plastic and Reconstructive Surgery. » Read more

 

May 23 2016: Press release: Basel network for breast cancer research expands to Europe (in German)

 



"...the practice of medicine will become increasingly interdisciplinary, requiring clinicians to work with biologists and physicists, chemists, engineers, and computational experts to deal with diagnostics and to invent novel ways to intervene..."
"We must also think about time scales. The university must pursue fundamental discovery research for long-term benefits, translational research for the medium-term application, and patients-based application for short-term, if not immediate results. All three must find their place in a dialogue within the faculty."

From "The future of medicine" (Schwabe Verlag Basel 2013, 10-22) by Susan M. Gasser, FMI Director.